Beneficiaries
InPharma consists of 11 Beneficiaries who will employ the 13 Early Stage Resarchers (ESRs) uniting world-leading academic research groups and pharma companies on their common search for better drug formulation processes which lead to safer and more efficient drugs for patients while simultaneously eradicating animal testing from the process and reducing development costs.
Academic Beneficiaries
B1: University College Cork, School of Pharmacy (UCC), Ireland
Team Leader: Prof. Brendan Griffin
B2: Fraunhofer Gesellschaft zur Förderung der angewandten Forschung E.V., Department of Translational Medicine and Pharmacology ITMP (Fraunhofer ITMP), Germany
Team Leader: Prof. Jennifer Dressman
B3: National and Kapodistrian University of Athens, Department of Pharmacy, Section of Pharmaceutical Technology (NKUA), Greece
Team Leader: Prof. Christos Reppas
B4: University of Southern Denmark, Department of Physics, Chemistry & Pharmacy (SDU), Denmark
Team Leader: Prof. Annette Bauer-Brandl
B5: University of Applied Sciences & Arts Northwestern Switzerland, Institute of Pharma Technology (FHNW)
Team Leader: Prof. Martin Kuentz
Industry Beneficiaries
B6: AstraZeneca AB, Early Product Development (AZ), Sweden
Team Leader: Sara Carlert
B7: Bayer AG, Pharmaceutical R&D (Bayer), Germany
Team Leader: Dr. André Dallmann
B8: Janssen Pharmaceutica NV, Drug Product Development (Janssen), Belgium
Team Leader: Dr. Rene Holm
B9: F. Hoffmann- La Roche AG, Pharmaceutical R&D (Roche), Switzerland
Team Leader: Dr. Nicole Wyttenbach
B10: Solvias AG, Solid-State Development (Solvias), Switzerland
Team Leader: Dr. Rolf Hilfiker
B11: Zentiva K.S., Drug Product Development (Zentiva), Czech Republic
Team Leader: Dr. Josef Beranek